Light Sciences Oncology raises $35 million in debt and option financing
This article was originally published in Scrip
Executive Summary
Light Sciences Oncology has secured a $23.3 million credit facility as well as $11.8 million in warrants. The US firm, which develops light-activated drug products for the treatment of solid tumours, has not yet determined the use of the proceeds.